Alyeska Investment Group, L.P.

Position in CRL — Charles River Laboratories International, Inc.

CIK 1453072 CHICAGO, IL

Position in CRL

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$53,295,650

-$43,068,542 QoQ

Shares Held

235,000

-57.9% QoQ

Ownership

0.492%

of shares outstanding

% of Portfolio

0.15%

of 13F equity value

Holder Rank

#50

of 564 holders

Holding Since

Jun 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Alyeska Investment Group, L.P. holds $929,620,379 across 10 Diagnostics & Research names. CRL ranks #8 (5.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IDXX	Idexx Laboratories Inc /De	401,082	$211,145,608
2	TMO	Thermo Fisher Scientific Inc.	376,071	$188,546,956
3	A	Agilent Technologies, Inc.	814,971	$108,252,597
4	ILMN	Illumina, Inc.	581,730	$102,285,585
5	GH	Guardant Health, Inc.	647,818	$97,192,134
6	RDNT	RadNet, Inc.	1,171,721	$72,260,034
7	DHR	Danaher Corp /De/	310,000	$59,048,800
8	CRL	Charles River Laboratories International, Inc. This page	235,000	$53,295,650

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$53,295,650	235,000	-57.9%	Shares	Sole	2026-08-14
2026-03-31	$96,364,192	558,633	-13.4%	Shares	Sole	2026-05-15
2025-12-31	$128,609,942	644,726	+120.7%	Shares	Sole	2026-02-13
2025-09-30	$45,714,013	292,177	-0.2%	Shares	Sole	2025-11-17
2025-06-30	$44,413,191	292,712	+46.2%	Shares	Sole	2025-08-14
2024-12-31	$36,968,365	200,262	-39.9%	Shares	Sole	2025-02-14
2022-09-30	$65,618,827	333,429	+37.4%	Shares	Sole	2022-11-14
2022-06-30	$51,928,807	242,692	+0.1%	Shares	Sole	2022-08-15
2022-03-31	$68,881,467	242,566	+27.5%	Shares	Sole	2022-05-17
2021-12-31	$71,681,264	190,247	+71.5%	Shares	Sole	2022-02-14
2021-09-30	$45,770,055	110,912	+81.9%	Shares	Sole	2021-11-15
2021-06-30	$22,555,872	60,975	-24.1%	Shares	Sole	2021-08-16
2020-06-30	$14,001,176	80,305	—	Shares	Sole	2020-08-14
No filing history on record for this holder in this stock.